|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2008-7-2
|
|
pubmed:abstractText |
To investigate the impact of adding rituximab to intensive chemotherapy with peripheral-blood progenitor cell (PBPC) autograft for high-risk diffuse large B-cell lymphoma (DLB-CL) and follicular lymphoma (FL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal...,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating...,
http://linkedlifedata.com/resource/pubmed/chemical/Melphalan,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Thiotepa,
http://linkedlifedata.com/resource/pubmed/chemical/rituximab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BarbuiTizianoT,
pubmed-author:BenedettiFabioF,
pubmed-author:BoccadoroMarioM,
pubmed-author:CiceriFabioF,
pubmed-author:CorradiniPaoloP,
pubmed-author:CortelazzoSergioS,
pubmed-author:GallaminiAndreaA,
pubmed-author:GianniAlessandro MAM,
pubmed-author:MagniMicheleM,
pubmed-author:MajolinoIgnazioI,
pubmed-author:MirtoSalvoS,
pubmed-author:PasseraRobertoR,
pubmed-author:PattiCaterinaC,
pubmed-author:PileriAlessandroA,
pubmed-author:PizzoloGiovanniG,
pubmed-author:RambaldiAlessandroA,
pubmed-author:TarellaCorradoC,
pubmed-author:ZanniManuelaM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3166-75
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18490650-Adolescent,
pubmed-meshheading:18490650-Adult,
pubmed-meshheading:18490650-Aged,
pubmed-meshheading:18490650-Antibodies, Monoclonal,
pubmed-meshheading:18490650-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:18490650-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18490650-Cisplatin,
pubmed-meshheading:18490650-Cyclophosphamide,
pubmed-meshheading:18490650-Cytarabine,
pubmed-meshheading:18490650-Disease Progression,
pubmed-meshheading:18490650-Etoposide,
pubmed-meshheading:18490650-Female,
pubmed-meshheading:18490650-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:18490650-Humans,
pubmed-meshheading:18490650-Italy,
pubmed-meshheading:18490650-Lymphoma, Follicular,
pubmed-meshheading:18490650-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:18490650-Male,
pubmed-meshheading:18490650-Melphalan,
pubmed-meshheading:18490650-Methotrexate,
pubmed-meshheading:18490650-Middle Aged,
pubmed-meshheading:18490650-Prognosis,
pubmed-meshheading:18490650-Proportional Hazards Models,
pubmed-meshheading:18490650-Retrospective Studies,
pubmed-meshheading:18490650-Risk Factors,
pubmed-meshheading:18490650-Survival Rate,
pubmed-meshheading:18490650-Thiotepa,
pubmed-meshheading:18490650-Transplantation, Autologous,
pubmed-meshheading:18490650-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
|
|
pubmed:affiliation |
Dipartimento Medicina-Oncologia Sperimentale, Divisione Universitaria di Ematologia, Az. Osp. S. Giovanni Battista, Via Genova 3, 10126 Torino, Italy. corrado.tarella@unito.it
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
